Clinical Trial Update: Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO [Phase 3]

View source ↗

Summary

Phase 3 trial investigating periorbital glucocorticoid injections for mild thyroid-associated ophthalmopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• Glucocorticoid (glucocorticoid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thyroid Associated Ophthalmopathy | Phase 3 | Status: UNKNOWN